WO2006119499A3 - Use of phycotoxins in veterinary applications - Google Patents

Use of phycotoxins in veterinary applications Download PDF

Info

Publication number
WO2006119499A3
WO2006119499A3 PCT/US2006/017449 US2006017449W WO2006119499A3 WO 2006119499 A3 WO2006119499 A3 WO 2006119499A3 US 2006017449 W US2006017449 W US 2006017449W WO 2006119499 A3 WO2006119499 A3 WO 2006119499A3
Authority
WO
WIPO (PCT)
Prior art keywords
phycotoxins
veterinary applications
compositions
propinoperhydropurines
tricyclic
Prior art date
Application number
PCT/US2006/017449
Other languages
French (fr)
Other versions
WO2006119499A2 (en
Inventor
Nestor Antonio Lagos Wilson
Original Assignee
Phytotox Ltd
Micro Algae Corp
Nestor Antonio Lagos Wilson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytotox Ltd, Micro Algae Corp, Nestor Antonio Lagos Wilson filed Critical Phytotox Ltd
Priority to EP06752321A priority Critical patent/EP1877058A4/en
Priority to CA002606315A priority patent/CA2606315A1/en
Priority to JP2008510273A priority patent/JP2008540452A/en
Priority to AU2006243644A priority patent/AU2006243644A1/en
Publication of WO2006119499A2 publication Critical patent/WO2006119499A2/en
Publication of WO2006119499A3 publication Critical patent/WO2006119499A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Abstract

Pharmaceutical compositions comprising tricyclic 3,4-propinoperhydropurines and uses thereof which for providing a local anesthetic, muscle relaxant, facilitating wound healing, and immobilization to an animal are provided. Also provided are a variety of methods of treating animals using the compositions of the invention.
PCT/US2006/017449 2005-05-05 2006-05-05 Use of phycotoxins in veterinary applications WO2006119499A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP06752321A EP1877058A4 (en) 2005-05-05 2006-05-05 Use of phycotoxins in veterinary applications
CA002606315A CA2606315A1 (en) 2005-05-05 2006-05-05 Use of phycotoxins in veterinary applications
JP2008510273A JP2008540452A (en) 2005-05-05 2006-05-05 Use of phycotoxins in veterinary applications
AU2006243644A AU2006243644A1 (en) 2005-05-05 2006-05-05 Use of phycotoxins in veterinary applications

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67793305P 2005-05-05 2005-05-05
US60/677,933 2005-05-05

Publications (2)

Publication Number Publication Date
WO2006119499A2 WO2006119499A2 (en) 2006-11-09
WO2006119499A3 true WO2006119499A3 (en) 2006-12-28

Family

ID=37308745

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/017449 WO2006119499A2 (en) 2005-05-05 2006-05-05 Use of phycotoxins in veterinary applications

Country Status (5)

Country Link
EP (1) EP1877058A4 (en)
JP (1) JP2008540452A (en)
AU (1) AU2006243644A1 (en)
CA (1) CA2606315A1 (en)
WO (1) WO2006119499A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11236097B2 (en) 2017-03-29 2022-02-01 Siteone Therapeutics, Inc. 11,13-modified saxitoxins for the treatment of pain

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100574A1 (en) * 2001-11-15 2003-05-29 Wilson Nestor Antonio Lagos Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024419A1 (en) * 1998-10-27 2000-05-04 Mayo Foundation For Medical Education And Research Methods for enhancing wound healing
BRPI0510759A (en) * 2004-05-07 2007-11-20 Phytotox Ltd method of facilitating healing of an injury

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100574A1 (en) * 2001-11-15 2003-05-29 Wilson Nestor Antonio Lagos Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1877058A4 *

Also Published As

Publication number Publication date
CA2606315A1 (en) 2006-11-09
AU2006243644A1 (en) 2006-11-09
EP1877058A4 (en) 2008-06-25
WO2006119499A2 (en) 2006-11-09
EP1877058A2 (en) 2008-01-16
JP2008540452A (en) 2008-11-20

Similar Documents

Publication Publication Date Title
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2005116088A3 (en) Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
NO20085338L (en) Substituted 1,3-diphenylpropane derivatives, compositions and uses thereof
WO2005123116A3 (en) Compositions and methods for treating or preventing oxalate-related disease
ATE453642T1 (en) SUBSTITUTED PHENYLAMINOPYRIMIDINES
BRPI0717219A2 (en) "immunogenic composition, method for treating or preventing disease, and use of an immunogenic composition."
BRPI0709581A8 (en) bicycloetheroyl compounds as px27 modulators and their use
IL184051A (en) Acylated glp-1 compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
ATE537819T1 (en) NUTRACEUTICAL COMPOSITIONS FOR TREATING MUSCLE WASTING
PT1313489E (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BEHCET MUCOSITE, STOMATITIS AND SINDROMA
EA200900211A1 (en) SUBSTITUTED IMIDAZOLONE DERIVATIVES, THEIR RECEIVING AND APPLICATION
WO2007118963A3 (en) Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
DE602004015907D1 (en) Conjugated dienamides, process for their preparation, compositions containing them and their use
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
WO2008087367A3 (en) Substituted (phenylthiazolyl)-phenyl-propan-1-one and (phenyloxazodyl)-phenyl-propan-1-one derivatives, preparations and uses of same
WO2007009701A3 (en) Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
IL189104A (en) Pharmaceutical preparation comprising balsalazide or balsalazide disodium for use in treating gastrointestinal disease
WO2007009686A3 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2008105088A1 (en) Agent for treating spinal cord injury
PL3156057T3 (en) Delmopinol-coated animal chew for use in the prevention or treatment of halitosis
WO2008027551A3 (en) Dendrimer compositions
EP1709155A4 (en) Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
WO2009053628A3 (en) Novel compounds, preparation and uses thereof
EP2801359A3 (en) The use of nicotine for the treatment of sepsis in humans caused by antibiotic

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006243644

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2606315

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006752321

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2008510273

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU